These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 27186978)

  • 1. Cell Type Preference of a Novel Human Derived Cell-Permeable Peptide dNP2 and TAT in Murine Splenic Immune Cells.
    Lim S; Lee JA; Koo JH; Kang TG; Ha SJ; Choi JM
    PLoS One; 2016; 11(5):e0155689. PubMed ID: 27186978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LRR domain of NLRX1 protein delivery by dNP2 inhibits T cell functions and alleviates autoimmune encephalomyelitis.
    Koo JH; Kim DH; Cha D; Kang MJ; Choi JM
    Theranostics; 2020; 10(7):3138-3150. PubMed ID: 32194859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of human T cell responses by dNP2-ctCTLA-4 inhibits human skin and microvessel graft rejection.
    Lim S; Kirkiles-Smith NC; Pober JS; Bothwell ALM; Choi JM
    Biomaterials; 2018 Nov; 183():128-138. PubMed ID: 30165256
    [TBL] [Abstract][Full Text] [Related]  

  • 4. dNP2 is a blood-brain barrier-permeable peptide enabling ctCTLA-4 protein delivery to ameliorate experimental autoimmune encephalomyelitis.
    Lim S; Kim WJ; Kim YH; Lee S; Koo JH; Lee JA; Yoon H; Kim DH; Park HJ; Kim HM; Lee HG; Yun Kim J; Lee JU; Hun Shin J; Kyun Kim L; Doh J; Kim H; Lee SK; Bothwell ALM; Suh M; Choi JM
    Nat Commun; 2015 Sep; 6():8244. PubMed ID: 26372309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative Immunogenicity of a Cytotoxic T Cell Epitope Delivered by Penetratin and TAT Cell Penetrating Peptides.
    Brooks N; Esparon S; Pouniotis D; Pietersz GA
    Molecules; 2015 Aug; 20(8):14033-50. PubMed ID: 26247926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Internalization routes of cell-penetrating melanoma antigen peptides into human dendritic cells.
    Buhl T; Braun A; Forkel S; Möbius W; van Werven L; Jahn O; Rezaei-Ghaleh N; Zweckstetter M; Mempel M; Schön MP; Haenssle HA
    Exp Dermatol; 2014 Jan; 23(1):20-6. PubMed ID: 24372650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved anticancer efficacy of doxorubicin mediated by human-derived cell-penetrating peptide dNP2.
    Xiang Y; Shan W; Huang Y
    Int J Pharm; 2018 Nov; 551(1-2):14-22. PubMed ID: 30205127
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-targeted paclitaxel delivery and enhanced penetration using TAT-decorated liposomes comprising redox-responsive poly(ethylene glycol).
    Fu H; Shi K; Hu G; Yang Y; Kuang Q; Lu L; Zhang L; Chen W; Dong M; Chen Y; He Q
    J Pharm Sci; 2015 Mar; 104(3):1160-73. PubMed ID: 25449709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cell membrane penetrating function of the nuclear localization sequence in human cytokine IL-1α.
    Koo JH; Yoon H; Kim WJ; Lim S; Park HJ; Choi JM
    Mol Biol Rep; 2014 Dec; 41(12):8117-26. PubMed ID: 25205122
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of electronic-neutral penetrating peptides cyclosporin A to deliver pro-apoptotic peptide: A possibly better choice than positively charged TAT.
    Gao W; Yang X; Lin Z; He B; Mei D; Wang D; Zhang H; Zhang H; Dai W; Wang X; Zhang Q
    J Control Release; 2017 Sep; 261():174-186. PubMed ID: 28662902
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tat(48-60) peptide amino acid sequence is not unique in its cell penetrating properties and cell-surface glycosaminoglycans inhibit its cellular uptake.
    Subrizi A; Tuominen E; Bunker A; Róg T; Antopolsky M; Urtti A
    J Control Release; 2012 Mar; 158(2):277-85. PubMed ID: 22100438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of TAT cell membrane penetration efficiency by dimethyl sulphoxide.
    Wang H; Zhong CY; Wu JF; Huang YB; Liu CB
    J Control Release; 2010 Apr; 143(1):64-70. PubMed ID: 20025914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Induction of neutralizing antibodies and Th1-polarized and CD4-independent CD8+ T-cell responses following delivery of human immunodeficiency virus type 1 Tat protein by recombinant adenylate cyclase of Bordetella pertussis.
    Mascarell L; Fayolle C; Bauche C; Ladant D; Leclerc C
    J Virol; 2005 Aug; 79(15):9872-84. PubMed ID: 16014948
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intracellular Delivery of Nanoparticles with Cell Penetrating Peptides.
    Salzano G; Torchilin VP
    Methods Mol Biol; 2015; 1324():357-68. PubMed ID: 26202282
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring novel and potent cell penetrating peptides in the proteome of SARS-COV-2 using bioinformatics approaches.
    Kardani K; Bolhassani A
    PLoS One; 2021; 16(2):e0247396. PubMed ID: 33606823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Efficiency of Tat Cell Penetrating Peptide for Intracellular Uptake of HIV-1 Nef Expressed in E. coli and Mammalian Cell.
    Kadkhodayan S; Bolhassani A; Sadat SM; Irani S; Fotouhi F
    Curr Drug Deliv; 2017; 14(4):536-542. PubMed ID: 27719633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HBcAg18-27 epitope fused to HIV-Tat 49-57 adjuvanted with CpG ODN induces immunotherapeutic effects in transgenic mice.
    Wang S; Han Q; Zhang N; Chen J; Liu Z; Zhang G; Li Z
    Immunol Lett; 2010 Jan; 127(2):143-9. PubMed ID: 19883689
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progress in Research and Application of HIV-1 TAT-Derived Cell-Penetrating Peptide.
    Zou L; Peng Q; Wang P; Zhou B
    J Membr Biol; 2017 Apr; 250(2):115-122. PubMed ID: 27933338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential expression of murine CD81 highlighted by new anti-mouse CD81 monoclonal antibodies.
    Maecker HT; Todd SC; Kim EC; Levy S
    Hybridoma; 2000 Feb; 19(1):15-22. PubMed ID: 10768837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Peptide delivery into cells by using the synergistic effects of a cell-penetrating Peptide and a chemical drug to alter cell permeability.
    Ma JL; Wang H; Wang YL; Luo YH; Liu CB
    Mol Pharm; 2015 Jun; 12(6):2040-8. PubMed ID: 25886885
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.